Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (2): 128-130.DOI: 10.3969/j.issn.1673-8640.2016.02.012
• Orginal Article • Previous Articles Next Articles
Received:2015-10-23
Online:2016-02-20
Published:2016-04-07
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.02.012
| 标本号 | 病例 | AU5800 | 旗标 | DXC800 |
|---|---|---|---|---|
| 1 | 1 | -23.0 | G | 238 |
| 2 | 1 | 99.9 | 无 | 289 |
| 3 | 2 | 8.6 | G | 384 |
| 标本号 | 病例 | AU5800 | 旗标 | DXC800 |
|---|---|---|---|---|
| 1 | 1 | -23.0 | G | 238 |
| 2 | 1 | 99.9 | 无 | 289 |
| 3 | 2 | 8.6 | G | 384 |
| 序号 | 患者标本 | 正常人标本 | 混合标本 | |
|---|---|---|---|---|
| 1 h | 2 h | |||
| 1 | 99.9 | 385.3 | 75.0 | 77.0 |
| 2 | 107.0 | 384.6 | 77.1 | 83.7 |
| 3 | 96.9 | 388.1 | 76.1 | 76.0 |
| 4 | 289.0 | 374.0 | 338.0 | 335.0 |
| 5 | 289.0 | 375.0 | 336.0 | 340.0 |
| 6 | 287.0 | 374.0 | 335.0 | 338.0 |
| 序号 | 患者标本 | 正常人标本 | 混合标本 | |
|---|---|---|---|---|
| 1 h | 2 h | |||
| 1 | 99.9 | 385.3 | 75.0 | 77.0 |
| 2 | 107.0 | 384.6 | 77.1 | 83.7 |
| 3 | 96.9 | 388.1 | 76.1 | 76.0 |
| 4 | 289.0 | 374.0 | 338.0 | 335.0 |
| 5 | 289.0 | 375.0 | 336.0 | 340.0 |
| 6 | 287.0 | 374.0 | 335.0 | 338.0 |
| 加样流程 | 加样顺序 | 尿酸（µmol/L） |
|---|---|---|
| 流程一 | 2R1→标本→R2 | 31 |
| 流程二 | R1→标本→R2+R1 | -328 |
| 流程三 | R1+R2→标本 | 318 |
| 加样流程 | 加样顺序 | 尿酸（µmol/L） |
|---|---|---|
| 流程一 | 2R1→标本→R2 | 31 |
| 流程二 | R1→标本→R2+R1 | -328 |
| 流程三 | R1+R2→标本 | 318 |
| [1] | ROCK KL,KATAOKA H,LAI JJ.Uric acid as a danger signal in gout and its comorbidities[J]. Nat Rev Rheumatol,2013,9(1):13-23. |
| [2] | GIORDANO C,KARASIK O,KING-MORRIS K,et al.Uric acid as a marker of kidney disease: review of the current literature[J]. Dis Markers,2015,2015:382918. |
| [3] | JOHNSON RJ,LANASPA MA,GAUCHER EA.Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations[J]. Semin Nephrol,2011,31(5):394-399. |
| [4] | FOSSATI P,PRENCIPE L,BERTI G.Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine[J]. Clin Chem,1980,26(2):227-231. |
| [5] | SHEPPARD CA,ALLEN RC,AUSTIN GE,et al.Paraprotein interference in automated chemistry analyzers[J]. Clin Chem,2005,51(6):1077-1078. |
| [6] | MAILANKODY S,MENA E,YUAN CM,et al.Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma[J]. Leuk Lymphoma,2010,51(12):2159-2170. |
| [7] | LANGMAN LJ,ALLEN LC,ROMASCHIN AD.Interference of IgM paraproteins in the Olympus AU800 uric acid assay[J]. Clin Biochem,1998,31(7):517-521. |
| [8] | BERTH M,DELANGHE J.Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature[J]. Acta Clin Belg,2004,59(5):263-273. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
